Who Paid My Doc
Kayla Babcock
Nurse Practitioner, Family Warwick, RI Nurse Practitioner
NPI 1508490350 CMS profile 10485672
2870 Post Rd, Warwick, RI 02886
General payments
$3,839
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Kayla Babcock of Warwick, RI is reported in the CMS Open Payments database as having received $3,839 across 232 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 91st percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $79 | 2 | |
| 2022 | General | $1,860 | 108 | |
| 2021 | General | $1,900 | 122 |
Beside peers
- Kayla Babcock
- Nurse Practitioner, Family median
- Middle half of Nurse Practitioner, Family
- National median
In program year 2025, general payments to Kayla Babcock were reported at $0. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.
Show as a table
| Year | Kayla Babcock | Nurse Practitioner, Family median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $39 | $18–$91 | $163 |
| 2020 | $0 | $32 | $17–$76 | $114 |
| 2021 | $1,900 | $124 | $35–$379 | $132 |
| 2022 | $1,860 | $141 | $44–$430 | $149 |
| 2023 | $79 | $154 | $49–$476 | $160 |
| 2024 | $0 | $165 | $51–$504 | $164 |
| 2025 | $0 | $168 | $53–$521 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 52 drugsPart D claims
1,652
Drug cost
$77,421
Branded share of claims
19.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 77 | $21,756 | |
| Movantik Naloxegol Oxalate | Brand | 42 | $9,786 | |
| Rexulti Brexpiprazole | Brand | 15 | $8,387 | |
| Buprenorphine | Generic | 16 | $3,212 | |
| Symproic Naldemedine Tosylate | Brand | 12 | $2,389 | |
| Pregabalin | Generic | 46 | $2,291 | |
| Levetiracetam | Generic | 29 | $2,274 | |
| Ramelteon | Generic | 13 | $2,253 | |
| Carbidopa-Levodopa Carbidopa/Levodopa | Brand | 44 | $1,890 | |
| Autoshield Duo Pen Needle Pen Needle,dual Safety,diabetc | Brand | 18 | $1,869 |
The 10 drugs with the highest cost, of 52 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$137,722
Medicare patients
277
Services billed
1,930
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Depression | 75% | |
| Arthritis | 60% | |
| Alzheimer's or dementia | 59% | |
| Heart failure | 56% | |
| Chronic kidney disease | 45% | |
| Diabetes | 38% | |
| Atrial fibrillation | 36% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
232 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Family in Rhode Island
Carol Robinson
Nurse Practitioner, Family · Warwick, RI
Mark Clarke
Nurse Practitioner, Family · Smithfield, RI
Olga Fedorenko
Nurse Practitioner, Family · Coventry, RI
Alicia Vatter
Nurse Practitioner, Family · Warwick, RI
Kaleigh Rapoza
Nurse Practitioner, Family · Johnston, RI
David Ramos
Nurse Practitioner, Family · Riverside, RI
Related records
Nurse Practitioner, Family in Rhode Island
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Family
Everyone recorded under this specialty, nationwide.
Doctors in Rhode Island
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.